Opposing Views

Journal of Urology

Volumn 181, Issue 5, 2009, Pages 1994-1997

  deVere White, Ralph W ^a   Katz, Mark H ^b   Steinberg, Gary D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE; ANTINEOPLASTIC AGENT;

ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER MORTALITY; CYSTECTOMY; HUMAN; MICROMETASTASIS; MORBIDITY; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; ADJUVANT THERAPY; BLADDER TUMOR; FEMALE; MALE; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SURVIVAL;

ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYSTECTOMY; FEMALE; HUMANS; MALE; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 64049091087     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.02.052     Document Type: Article

References (16)

1. Herr H.W., Dotan Z., Donat S.M., and Bajorin D.F. Defining optimal therapy for muscle invasive bladder cancer. J Urol 177 (2007) 437
2. Grossman H.B., Natale R.B., and Tangen C.M. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859 [Erratum: N Engl J Med 2003; 349: 1880]
3. Hall R.R., Intl Collaboration of Trialists of the MRC Advanced Bladder Cancer Group, MRC Clinical Trials Unit, London, and UK. Updated results of a randomized controlled trial of neoadjuvant cisplatin (C) methotrexate (M) and vinblastine (V) chemotherapy for muscle invasive bladder cancer. Proc AM Soc Clin Oncol (2002) abstract 710
4. Millikan R., Dinney C., Swanson D., Sweeney P., Ro J.Y., Smith T.L., et al. Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol 19 (2001) 4005
5. Dash A., Pettus J.A., Herr H.W., Bochner B.H., Dalbagni G., Russo P., et al. A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience cancer. Cancer 113 (2008) 2471
6. Herr H.W., Faulkner J.R., Grossman H.B., Natale R.B., deVere White R., Sarosdy M.F., et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 22 (2004) 2781
7. Chamie K, Hu B, deVere White RW and Ellison LM: Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? Unpublished data.
8. David K.A., Milowsky M.I., Ritchey J., Carroll P.R., and Nanus D.M. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. J Urol 178 (2007) 451
9. Stein J.P., Lieskovsky G., Cote R., Groshen S., Feng A.C., Boyd S., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666
10. Herr H.W. Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol 54 (2008) 126
11. Bassi P., Pagano F., and Pappagallo P. Neoadjuvant M-VAC of invasive bladder cancer: the G.U.O.N.E. multicenter phase III trial. Eur Urol 33 suppl. (1998) 142
12. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists. Lancet 354 (1999) 533
13. Advanced Bladder Cancer Meta-analysis Colloboration: Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361 (2003) 1927
14. Lehmann J., Franzaring L., Thuroff J., Wellek S., and Stockle M. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer. BJU Int 97 (2006) 42
15. Skinner D.G., Daniels J.R., Russell C.A., Lieskovsky G., Boyd S.D., Nichols P., et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 145 (1991) 459
16. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration: Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data. Eur Urol 48 (2005) 189